Pharmacological treatment of post-traumatic behavioural disorders;Traitement pharmacologique des troubles du comportement post-traumatiques

Annales de Readaptation et de Medecine Physique

Volumn 46, Issue 1, 2003, Pages 49-57

  Richard, I ^a   Perrouin Verbe, B ^b   Rome, J ^b   Bernat, C ^a   Mathe J F ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Agitation; Agressivity; Behaviour; Pharmacology; Traumatic Brain Injury

Indexed keywords

AMANTADINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; LEVOMEPROMAZINE; LITHIUM; METHYLPHENIDATE; NEUROLEPTIC AGENT; PROPRANOLOL; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VALPROIC ACID;

AGGRESSIVENESS; AGITATION; ARTICLE; BEHAVIOR DISORDER; CLINICAL TRIAL; DRUG EFFICACY; EXCITABILITY; HOSTILITY; HUMAN; MENTAL INSTABILITY; POSTTRAUMATIC COMPLICATION; PSYCHOPHARMACOTHERAPY;

ADRENERGIC BETA-ANTAGONISTS; AGGRESSION; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BRAIN INJURIES; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; HUMANS; LITHIUM COMPOUNDS; MENTAL DISORDERS; METHYLPHENIDATE; PLACEBOS; PROSPECTIVE STUDIES; PSYCHOMOTOR AGITATION; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; TRANQUILIZING AGENTS;

EID: 0344520425     PISSN: 01686054     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6054(02)00353-7     Document Type: Article

References (71)

1. Alaoui P, Mazaux JM, Masson F, Vecsey J, Destaillats JM, Maurette P, Vanier M, Levin HS, Joseph PA, Barat M. Devenir neurospychologique à long terme des traumatisés crâniens, Évaluation à 5 ans des troubles neuropsychologiques et comportementaux par l'échelle neurocomportementale révisée (à propos de 79 cas). Ann Réadapt Méd Phys 1998;41:171-81.
2. Albani F, Riva R, Baruzzi A. Carbamazepine clinical pharmacology: A review. Pharmacopsychiat 1995;28:235-44.
3. Alderman N, Davies JA, Jones C, McDonnel P. Reduction of severe aggressive behaviour in acquired brain injury: Case studies illustrating clinical use of the OAS-MNR in the management of challenging behaviours. Brain Inj 1999;13:669-704.
4. ANAES, Guide d'analyse des recommandations et gradations des recommandations Janvier 2000. www.ANAES.fr.
5. Azouvi P, Jokic C, Attal N, Denys P, Markabi S, Bussel B. Carbamazepine in agitation and aggressive behaviour following severe closed head injury: results of an open trial. Brain Inj 1999;13:797-804.
6. Baguley I., Green A., Slewa-Younan S., Simpson S., Agressive behavior following traumatic brain injury: How common is common? 3rd world congress in neurological rehabilitation Avril 2-6 (2002) Venise.
7. Bascunana H, Villareal I, Alfonso S, Bernabeu M, Terre R. Agitation en el traumatismo cranioencefalico. I, definicion y tratamiento con neurolepticos, ansioliticos y antiepilepticos. Rev Neurol 2000;30:850-4.
8. Bascunana H, Villareal I, Alfonso S, Terre R, Bernabeu M. Agitation en el traumatismo cranioencefalico. II, tratamiento con antidepresivos, simpaticomimeticos, betabloqueantes, dopaminergicos y otros farmacos. Rev Neurol 2000;30:1044-7.
9. Bellus SB, Stewart D, Vergo JG, Kost PP, Grace J, Barkstrom SR. The use of Lithium in the treatment of aggressive behaviours with two brain injured individuals in a state psychiatric hospital. Brain Inj 1996;10:849-60.
10. Bouvy PF, van de Wetering BJM, Meerwaldt JD, Bruijin JB. A case of organic brain syndrome following head injury successfully treated with carbamazepine. Acta Psychiatr Scand 1988;77:361-3.
11. Brooke MM, Patterson DR, Questad KA, Cardenas D, Farrel-Roberts L. The treatment of agitation during initial hospitalisation after traumatic brain injury. Arch Phys Med Rehabil 1992;73:917-21.
12. Brooks DN, McKinlay W. Personality and behavioural change after severe blunt head injury -A relative's view. J Neurol Neursurg Psychiatry 1983;46:336-44.
13. Challman TD, Lipsky JJ. Methylphenidate: It's pharmacology and uses. Mayo Clin Proc 2000;75:711-21.
14. Chatham-Showalter PE. Carbamazepine for combativeness in acute traumatic brain injury. J of Neuropsychiatry and clin neurosci 1996;8:96-9.
15. Corrigan JD. Development of a scale for assessment of agitation following traumatic brain injury. J Clin Exp Neuropsychology 1994;16:386-92.
16. Feeney DM, Gonzalez A, Law WA. Amphetamine, Haloperidol, and experience interact to affect the rate of recovery after motor cortex injury. Science 1982;217:855-7.
17. Ferrier IN. Lamotrigine and Gabapentin, Alternatives in the treatment of bipolar disorder. Neuropsychobiology 1998;38:192-7.
18. Fugate LP, Spacek LA, Kresty LA, Levy CE, Johnson JC, Mysiw WJ. Definition of agitation following traumatic brain injury: I A survey of the Brain Injury Special Interest Group of the american academy of physical medecine and rehabilitation. Arch Phys Med Rehab 1997;78:917-24.
19. Fugate LP, Spacek LA, Kresty LA, Levy CE, Johnson JC, Mysiw WJ. Measurement and treatment of agitation following traumatic brain injury: II A survey of the brain injury special interest group of the american academy of physical medecine and rehabilitation. Arch Phys Med Rehab 1997;78:924-8.
20. Geriacoti TD. Valproic acid treatment of episodic explosiveness related to brain injury. J Clin Psychiatry 1994;55:416-7.
21. Glenn MB, Wroblewski B, Parziale J, Levine L, Whyte J, Rosenthal M. Lithium Carbonate for aggressive behavior or affective instability in ten brain injured patients. Am J Phys Med Rehab 1989; 68:221-6.
22. Goldstein LB. Common drugs may influence motor recovery after stroke, The Sygen In Acute Stroke Study Investigators. Neurology 1996;46:1187-8.
23. Goldstein LB. Prescribing of potentially harmful drugs to patients admitted to hospital after head injury. J Neurol Neurosurg Psychiatry 1995;58:753-5.
24. Goscinski I, Kwiatkowski S, Polak J, Orlowiejska M, Partyk A. The Kluver Bucy Syndrome. J of Neurosurgical sciences 1997;41:269-72.
25. Gualtieri CT. Buspirone for the behavior problems of patients with organic brain disorders. J Clin Psychopharmacol 1991;11:280-1.
26. Jeanblanc W, Davis YB. Risperidone in treating dementia-associated aggression. Am J Psychiatry 1995;152:1239.
27. Kaelin DL, Cifu DX, Matthies B. Methylphenidate effect on attention deficit in the acutely brain-injured adult. Arch Phys Med Rehabil 1996;77:6-9.
28. Kraus MF. Neuropsychiatric sequelae of stroke and traumatic brain injury: The role of psychostimulants. Intl J Psychiatry in Medicine 1995;25:39-51.
29. Lemke MR. Effect of Carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics. J Clin Psychiatry 1995;56:354-7.
30. Levin HS, High VM, Goethe KE, Sisson RA, Overall JA, Rhoades HM, Eisenberg HM, Kalisky Z, Gary HE. The neurobehavioural rating scale: Assessment of the behavioural sequelae of head injury by clinician. J Neurol Neurosurg Psychiatry 1987;50:183-93.
31. Levin HS, Mazaux JM, Vanier M, Dartigues JF, Giroire JM, Daverat P, Pilon M, Hebert D, Johnson C, Fournier G, Barat M. Évaluation des troubles neuropsychologiques et comportementaux des traumatisés crâniens par le clinicien: proposition d'une échelle neurocomportementale et premiers résultats de la version française. Ann Réadapt Med Phys 1990;33:35-40.
32. Levine AM. Buspirone and agitation in head injury. Brain Injury 1988;2:165-7.
33. Lewin J, Sumners D. Successful treatment of episodic dyscontrol with carbamazepine. Br J of Psychiatry 1992;161:261-2.
34. Louis F, Richard I, Mauduyt de la Grève I, Perrouin-Verbe B, Mathé JF. Intérêt de la Carbamazépine dans la prise en charge des troubles de l'humeur et du comportement des traumatismes cranioencéphaliques graves. Ann Réadapt Méd Phys 1996;39(6):382.
35. Maryniak O, Manchada R, Velani A. Methotrimeprazine in the treatment of agitation in acquired brain injury patients. Brain Inj 2001;15:167-74.
36. Massagli TL. Neurobehavioral effects of phenytoin, carbamazepine and valproic acid: Implications for use in traumatic brain injury. Arch Phys Med Rehab 1991;72:219-26.
37. Mazaux JM, Masson F, Levin HS, Alaoui P, Maurette P, Barat M. Long term neuropsychological outcome and loss of social autonomy after traumatic brain injury. Arch Phys Med Rehabil 1997;78:1316-20.
38. Mellow AM, Solano-Lopez C, Davis S. Sodium Valproate in the treatment of behavioral disturbance in dementia. J of Geriatric Psychiatry and Neurology 1993;6:205-9.
39. Meythaler JM, Depalma L, DeVivo MJ, Guin-Renfroe S, Novack T. Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes. Brain Inj 2001;15:321-31.
40. Michals ML, Crismon ML, Roberts S, Childs A. Clozapine response and adverse effects in nine brain injured patients. J Clin Psychopharmacol 1993;13:198-203.
41. Mooney GF, Haas LJ. Effect of methylphenidate on brain injury related anger. Arch Phys Med Rehabil 1993;74:153-60.
42. Mysiw WJ, Jackson RD, Corrigan JD. Amitryptiline for post-traumatic agitation. Am J Phys Med Rehab 1988;1:29-33.
43. Mysiw WJ, Sandel ME. The agitated brain injury patient, Part 2: Pathophysiology and treatment. Arch Phys Med Rehabil 1997;78:213-20.
44. Nasrallah HA, Mulvihill T. Iatrogenic disorders associated with conventional vs, atypical antipsychotics. Ann Clin Psychiatry 2001;13:215-27.
45. Perino C, Rago R, Cicoloni A, Torta R, Monaco F. Mood and behavioral disorders following traumatic brain injury: clinical evaluation and pharmacological management. Brain Inj 2001;15:139-48.
46. Pourcher E, Filteau MJ, Bouchard RH, Baruch P. Efficacy of the combination of Buspirone and Carbamazépine in early posttraumatic delirium. Am J Psychiatry 1994;1:150-1.
47. Ratey JJ, Leveroni CL, Miller AC, Komry V, Gaffar K. Low dose Buspirone to treat agitation and maladaptive behavior in Brain Injured patients: Two case reports. J Clin Psychopharmacol 1992;12:362-4.
48. Reinhard DL, Whyte J, Sandel ME. Improved arousal and initiation following tricyclic antidepressant use in severe brain injury. Arch Phys Med Rehabil 1996;77:80-3.
49. Richard I, Fayol P. Indications et efficacité des traitements des troubles du comportement des traumatisés crâniens graves. Ann Réadapt Med Phys 2001;44:407.
50. Richard I, François C, Louis F, Mauduyt de la Grève I, Perrouin-Verbe B, Mathé JF. Epilepsie post-traumatique: analyse rétrospective d'une série de 90 traumatismes crâniens graves. Ann Réadapt Med Phys 1998;41:409-15.
51. Rommel O, Tegenthoff M, Widdig W, Braunig P, Malin JP. Organic catatonia following frontal lobe injury: response to Clozapine. J of Neuropsychiatry 10 1998:237-8.
52. Rowland TR, Mysiw J, Bogner JA, Corrigan J. Trazodone for post-traumatic agitation. Arch Phys Med Rehabil 1992;73:963.
53. Sandel E, Mysiw WJ. The agitated brain injury patient: Part 1: Definitions, differential diagnosis and assessment. Arch Phys Med Rehabil 1996;77:613-7.
54. Scheutzow MH, Wierceski DR. Panic disorder in a patient with traumatic brain injury: a case report and discussion. Brain Inj 1999;13:705-14.
55. Schneider WN, Drew-Cates J, Wong TM, Dombovy ML. Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double blind placebo-controlled study. Brain Injury 1999;13:863-72.
56. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990;38:553-63.
57. Simpson DM, Foster D. Improvement in organically disturbed behavior with Trazodone treatment. J Clin Psychiatry 1986;47:191-3.
58. Slaughter J, Bobo W, Childers MK. Selective serotonin reuptake inhibitor treatment of post-traumatic Kluver-Bucy syndrome. Brain Inj 1999;13:59-62.
59. Smith KR, Goulding PM, Wilderman D, Goldfader PR, Holtermann-Hommes P, Wei F. Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Arch Neurol 1994;51:653-60.
60. Speech TJ, Rao SM, Osmon DC, Sperry LT. A double blind study of methylphenidate treatment in closed head injury. Brain Inj 1993;7:333-8.
61. Stanislav SW. Cognitive effects of antipsychotic agents in persons with traumatic brain injury. Brain Inj 1997;11:335-41.
62. Stanislav SW, Fabre T, Crismon ML, Childs A. Buspirone's efficacy in organic induced aggression. J of Clin Psychopharmacology 1994;14:126-8.
63. Tariot PN, Erb R, Podgorski CA, Cox C, Patel S, Jakimovich L, Irvine C. Efficacy and tolerability of Carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998;155(1):54-61.
64. Tariot PN, Schneider LS, Katz IR. Anticonvulsivant and other non-neuroleptic treatment of agitation in dementia. J Geriatr Psychiatry Neurol 1995;8:S28-39.
65. Teng CJ, Bhalerao S, Lee Z, Farber J, Morris H, Foran T, Tucker W. The use of Bupropion in the treatment of restlessness after traumatic brain injury. Brain Inj 2001;15:463-7.
66. Truelle JL, Brooks DN, Potagas C, Joseph PA. A european chart of evaluation of patients with traumatic brain injury. In: Christensen AL, Uzelle BP, editors. Brain injury and neuropsychological rehabilitation. Hilsdale (NJ): Lawrence Erlbaum associates; 1994. p. 281-91.
67. Vanier M, Mazaux JM, Lambert J, Dassa C, Levin HS. Assessment of neuropsychologic impairments after head injury: interrater reliability and factorial and criterion validity of the neurobehavioral rating scale-revised. Arch Phys Med Rehabil 2000;81:796-806.
68. Wroblewski BA, Joseph AB. The use of intramuscular midazolam for acute seizure cessation or behavioral emergencies in patients with traumatic brain injury. J Neurol Neurosurg Psychiatry 1992;55:328-9.
69. Wroblewski BA. Non cognitive side effects of anticonvulsicant agents: monitoring patients with traumatic brain injury. J Head Traum Rehabil 1994;9:81-4.
70. Wroblewski BA, Joseph AB, Kupfer J, Kalliel K. Effectiveness of valproic acid on destructive and aggressive behaviours in patients with aquired brain injury. Brain Inj 1997;11:37-47.
71. Yudofski SC, Silver JM, Jackson W, Endicott J, Williams D. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986;143:35-9.